This content is restricted to site members. If you are an existing user, please log in. New users may register below.
Products
Zilobe
Prospect
Download pdfFormula
Each prolonged-release coated tablet contains 10 mg fampridine.
Mechanism of Action
A potassium channel blocker at the neuronal level. Zilobe is indicated to improve gait in adult patients with multiple sclerosis and a walking disability (EDSS 4-7).
Dosage and Administration
The recommended dose is one 10 mg tablet, twice a day, every 12 hours.
Package Size
A package containing 56 prolonged-release coated tablets.
Important Advice
By closing the window, you are accepting this message
The material included in this site has been designed for information purposes only. It intends to guide healthcare professionals in the correct use of the medications and satisfy their need for more information.
All texts referring to our prescription products meet the guidelines of the Argentine National Administration of Drugs and Medical Technology (ANMAT, its acronym in Spanish).
Synthon-Bagó Labs recommends that you always talk to a qualified healthcare professional if you have any questions or concerns regarding a specific medical condition.